Abbott Laboratories (NYSE:ABT) is included among the 15 Best Dividend Growth Stocks to Buy Now. On October 24, Citi analyst ...
The company shared new real-world findings for Aveir DR at the Asia Pacific Heart Rhythm Society (APHRS). These add to strong ...
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter ...
Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance. The company reported third-quarter sales of $11.37 billion, slightly ...
We recently published a list of 10 Stocks Jump, Defy Market Uncertainties on Thursday. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks ...
If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories (NYSE: ABT). Abbott is a longtime leader in the ...
Abbott Laboratories ABT is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback